Setting a new standard of care: a patient case series to reveal the impact of the new intermittent urinary catheter Luja
Abstract
This patient case series investigated the impact that the urinary catheter Luja™ with Micro-hole Zone Technology (MHZT) has had on the daily life of patients using intermittent catheters. With intermittent catheterisation (IC) representing the gold standard for daily bladder management for people with urinary tract dysfunctions, the novel urinary catheter Luja is designed to perform differently to conventional eyelet catheters and to address known urinary tract infection risk factors. Using semi-structured patient interviews conducted by health professionals, the real-life experiences of a diverse group of IC patients using the Luja catheter were collected. During the interviews most patients reported positive feedback from using the Luja catheter. Most mentioned perceiving a lower frequency of urinary tract infections, and many mentioned perceiving easier, faster and complete bladder emptying with the Luja catheter compared with their previous conventional eyelet catheter. These findings highlight the advantages that patients using the Luja catheter may experience during daily bladder management.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.